THENA Capital Launches £45M Fund for UK MedTech Startups
By Varun Mittal
THENA Capital closes £45M Fund I, the first all-female GP-led fund backed by British Business Bank, to invest in early-stage UK MedTech startups.
THENA Capital Closes £45M Fund I
THENA Capital has successfully closed its inaugural Fund I at £45 million, dedicated to investing in early-stage UK medical technology companies.
This marks a significant milestone as the first all-female, general-partner-led fund supported by the British Business Bank’s Enterprise Capital Funds program.
Key Investment Details
- Fund Size: £45 million for early-stage UK MedTech.
- Investment Target: Approximately 25 companies.
- Initial Seed Investments: Ranging from £500,000 to £1 million.
- Focus Areas: Digital health platforms and accelerated medical devices.
- Founding Team: Pamela Walker Geddes, Esther Reynal de St Michel Richardot, and Tatum Getty.
Addressing a Market Gap
The firm aims to address a critical lack of specialist capital and commercial expertise for UK MedTech innovations.
This support is crucial for these companies to scale globally.
Portfolio Companies
THENA Capital has already backed five companies: Plexāā, Salient Bio, Sanome, Heim, and Zonova.
The fund is actively deploying capital to build a high-conviction portfolio in the UK MedTech sector.